UC Davis Medical Group Physician's Referral Guide

Robert D. Cardiff, M.D. , Ph.D. , Ph.D.

Title: Distinguished Professor

Specialty: Pathology and Laboratory Medicine

Address:
Center for Comparative Medicine
County Rd. 98 and Hutchison Dr.
Davis, CA 95616

Phone:
(530) 752-2726


Undergraduate Education:	California Polytechnic State University San Luis Obispo, California UC Berkeley Berkeley, California B.S. 1958
Medical Education:	UC San Francisco School of Medicine San Francisco, California M.D. 1962
Other School:	University of California Berkeley, California Ph.D. 1968 , Ph.D. 1968
Internship:	Kings County General Hospital Brooklyn, New York 1962 rotating
Residency:	University of Oregon School of Medicine Portland, Oregon 1962-1966 Pathology
Board Certifications:	American Board of Pathology, 1969
Professional Memberships:	American Association for Cancer Research (AACR) American Association for the Advancement of Science (AAAS) American Association of University Professors (AAUP) American Society for Investigative Pathology (ASIP) American Society for Microbiology (ASM) Federation of American Societies for Experimental Biology (FASEB) International Academy of Pathology (IAP) International Association for Breast Cancer Research (IABCR)

Clinical/Research Interests: Dr. Cardiff's research interests include breast cancer, mouse models of human cancers, tumor and stem-cell biology, medical informatics, and optical imaging.
Publications: Cardiff RD, Munn RJ, Galvez JJ. The Tumor Pathology of Genetically Engineered Mice: A New Approach to Molecular Pathology. In: The Mouse in Biomedical Research: Experimental Biology and Oncology, Second Edition, Fox J, Barthold SW, eds., Vol. 2, Ch. 24, pp. 581-622, 2006. Shyamala G, Chou YC, Cardiff RD, Vargis E. Effect of c-neu/ErbB2 expression levels on estrogen receptor {alpha}-dependent proliferation in mammary epithelial cells: Implications for breast cancer biology. Cancer Res, 66:10391-8, 2006. Kwak EL, Kim S, Zhang J, Cardiff RD, Schmidt EV, Haber DA. Mammary tumorigenesis induced by expression of a dominant negative CHK2 allele. Cancer Res, 66:1923-1928, 2006. Fritz WA, Lin TM, Cardiff RD, Peterson RE. The aryl hydrocarbon receptor inhibits prostate carcinogenesis in TRAMP mice. Carcinogenesis, 2006. Derksen PW, Liu X, Saridin F, van der Gulden H, Zevenhoven J, Evers B, van Beijnum JR, Griffioen AW, Vink J, Krimpenfort P, Peterse JL, Cardiff RD, Berns A, Jonkers J. Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell, 10:437-449, 2006. Chodosh LA, Cardiff RD. In vivo imaging of the mammary gland: The shape of things to come. J Mammary Gland Biol Neoplasia, Nov 7, 2006. Cecena G, Wen F, Cardiff RD, Oshima RG. Different responses of mouse epithelial tissues to the polyoma middle-T oncogene. Am J Path, 168:310-320, 2006. Cardiff RD, Gregg JP, Miller JW, Axelrod DE, Borowsky AD. Histopathology as a predictive biomarker: Strengths and limitations. J Nutr, 136:2673S-2675S, 2006. Cardiff RD, Anver MR, Boivin GP, Bosenberg MW, Maronpot RR, Molinolo AA, Nikitin AY, Rehg JE, Thomas GV, Russell RG, Ward JM. Pre-cancer in mice: Animal models used to understand, prevent and treat human pre-cancers. Tox Path, 34:699-707, 2006. Borowsky AD, Dingley K, Ubick E, Turtletaub K, Cardiff RD, de Vere White R. Inflammation and atrophy precede prostate neoplasia in PhIP-induced rat model. Neoplasia, 8:708-715, 2006.
To schedule an appointment and to see if Dr.Cardiff is accepting new patients please call:
(530) 752-2726